Transplantation in HIV+ patients

Transplantation

Volumn 49, Issue 2, 1990, Pages 354-358

  Tzakis, Andreas G ^a,b   Cooper, Mark H ^a,b   Dummer, J Steven ^a,b   Ragni, Margaret ^a,b   Ward, John W ^a,b   Starzl, Thomas E ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGE; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; EPIDEMIOLOGY; ETIOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFANT; LATENT VIRUS INFECTION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE FACTORS; HEART TRANSPLANTATION; HIV SEROPOSITIVITY; HUMAN; INFANT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MIDDLE AGE; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS;

EID: 0025248293     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199002000-00025     Document Type: Article

References (28)

1. L’Age-Stehr, J, Schwarz A, Offerman G, et al. HTLV-III infection in kidney transplant recipients. Lancet 1985; 2: 1361.
2. Prompt CA, Reis MM, Grillo FM, et al. Transmission of AIDS virus at renal transplantation. Lancet 1985; 2: 672.
3. Dummer JS, Erb S, Breinig MK, et al. Infection with human immunodeficiency virus in the Pittsburgh transplant population: a study of 583 donors and 1043 recipients 1981-1986. Transplantation 1989; 47: 134.
4. Shaffer D, Pearl RH, Jenkins RL, et al. HTLV-III/LAV infection in kidney and liver transplantation. Transplant Proc 1987; 19: 2176.
5. Kerman RH, Flechner SM, Van Buren CT, et al. Investigation of HTLV-3 serology in a renal transplant population. Transplantation 1987; 43: 244.
6. Poli F, Scalamogna M, Pizzi C, Mozzi F, Sirchia G. HIV infection in cadaveric renal allograft recipients in the North Italy transplant program. Transplantation 1989; 47: 724.
7. Rubin RH, Jenkins RL, Shaw BW Jr, et al. The acquired immu nodeficiency syndrome and transplantation. Transplantation 1987; 44:1.
8. Baltimore-Boston Collaborative Study Group. Human immuno deficiency virus infection in hemodialysis patients. Arch Intern Med 1988; 148: 617.
9. Revision of the case definition for acquired immunodeficiency syndrome for national reporting—United States. MMWR 1985; 34, No. 25: 373.
10. Kusne S, Dummer JS, Singh N, et al. Infections after liver trans plantation: an analysis of 101 consecutive cases. Medicine 1988; 67: 132.
11. Fung JJ, Demetris AJ, Porter KA, et al. Use of OKT3 with ciclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron 1987; 46: 19.
12. Ragni MV, Winkelstein A, Kingsley L, Spero JA, Lewis JH. 1986 update of HIV seroprevalence, seroconversion, AIDS incidence, and immunology of HIV infection in patients with hemophilia A and B. Blood 1987; 70: 786.
13. Ward JW, Deppe DA, Samson S, et al. Risk of human immuno deficiency virus infection from blood donors who later developed the acquired immune deficiency syndrome. Ann Internal Med 1987; 106: 61.
14. Starzl TE, Demetris AJ, Van Thiel DH. Medical progress: liver transplantation. N Engl J Med 1989; 321: 1014 and 1092.
15. Ward JW, Schable C, Dickinson GM, et al. Acute human immu nodeficiency virus infection: antigen defection and seroconversion in immunosuppressed patients. Transplantation 1989; 47: 722.
16. Centers for Disease Control. Human immunodeficiency virus in fection transmitted from an organ donor screened for HIV antibody. MMWR 1987; 36: 306.
17. Friedland GH, Klein RS. Transmission of the human immunode ficiency virus. N Engl J Med 1987; 317: 1125.
18. Ward JW, Holmberg SD, Allen JR, et al. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. N Engl J Med 1988; 318: 473.
19. Polk BF, Fox R, Brookmeyer R, et al. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987; 316: 61.
20. Allain J-P, Laurian Y, Paul DA, et al. Long term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia: potential clinical importance. N Engl J Med 1987; 317: 1114.
21. Pedersen C, Nielsen CM, Vestergaard BF, Gerstoft J, Krogsgaard K, Nielsen JO. Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection. Br Med J 1987; 295: 567.
22. Murray HW, Godbold JH, Jurica KB, Roberts RB. Progression to AIDS in patients with lymphadenopathy or AIDS-related complex: reappraisal of risk and predictive factors. Am J Med 1989; 86: 533.
23. Eyster ME, Gail MH, Ballard JO, Al-Mondhiry H, Goedert JJ. Natural history of human immunodeficiency virus infection in hemophiliacs: effects of T-cell subsets, platelet counts and age. Ann Intern Med 1987; 107: 1.
24. Moss AR, Bacchetti P, Osmond D, et al. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J 1988; 296: 745.
25. Lifson AR, Rutherford, Jaffe HW. The natural history of human immunodeficiency virus infection. J Infect Dis 1988; 158: 1360.
26. Wilson SE, Robinson G, Williams RA, et al. Acquired immunode ficiency syndrome: indications for abdominal surgery, pathology and outcome. Ann Surg 1989; 210: 428.
27. Shapiro HB. Financing the care of patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 108: 470.
28. Hardy AM, Rauch K, Echenberg D, Morgan WM, Curran JW. The economic impact of the first 10,000 cases of acquired immunodeficiency syndrome in the United States. JAMA 1986; 255: 209.